Drug data last refreshed 19h ago · AI intelligence enriched 5d ago
NEO-CORT-DOME is a topical cream combining hydrocortisone (a corticosteroid) and neomycin sulfate (an antibiotic) for treating inflammatory and infected skin conditions. The hydrocortisone reduces inflammation and immune response while neomycin provides broad-spectrum antibacterial coverage. This combination formulation has been a dermatology staple since 1964.
As LOE approaches, the brand team is likely in harvest-and-defend mode with minimal growth investment; positions focus on managing generic transition and optimizing remaining patent-protected revenue.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on NEO-CORT-DOME offers limited career growth potential given its LOE-approaching status and zero linked job openings, making it a transitional or legacy brand assignment. This role is best suited for professionals seeking stable, defensive brand stewardship or those planning a move to growth-stage assets within a larger portfolio.
Worked on NEO-CORT-DOME at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.